Shandong Boan Biotechnology Co Ltd
06955
Company Profile
Business description
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, metabolism, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.
Contact
No. 39 Keji Avenue
High-Tech Industrial Development Zone
Shandong Province
Yantai
CHNT: +86 5354379111
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
402
Stocks News & Analysis
stocks
Another incredible quarter from Microsoft
We were wrong when we thought last quarter would be hard to top.
stocks
10 best US dividend aristocrats to buy now—including a surprise outperformer
These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks
Leading ASX players in this field look materially overvalued
We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,999.00 | 16.40 | -0.18% |
CAC 40 | 7,771.97 | 89.99 | -1.14% |
DAX 40 | 24,065.47 | 196.75 | -0.81% |
Dow JONES (US) | 44,130.98 | 330.30 | -0.74% |
FTSE 100 | 9,132.81 | 4.13 | -0.05% |
HKSE | 24,773.33 | 403.60 | -1.60% |
NASDAQ | 21,122.45 | 7.23 | -0.03% |
Nikkei 225 | 41,069.82 | 415.12 | 1.02% |
NZX 50 Index | 12,820.76 | 2.98 | -0.02% |
S&P 500 | 6,339.39 | 23.51 | -0.37% |
S&P/ASX 200 | 8,742.80 | 13.60 | -0.16% |
SSE Composite Index | 3,573.21 | 42.51 | -1.18% |